WEED, Inc.

BUDZ ·Healthcare, Diagnostics & Research, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-1.4M $-510.7K $-31.6K $-1.5M $-2.8M $-4.1M $-27.5M $-29.3M
Depreciation & Amortization $22.5K $22.6K $52.4K $111.4K $129.8K $145.8K $159.4K $180.6K
Depreciation $19.9K $20.0K $49.8K $106.1K $127.3K $145.8K — —
Amortization $2.6K $2.6K $2.5K $2.5K $2.5K $2.8K $2.6K $1.5K
Stock-Based Compensation $800.0K $20.0K — — $2.0M $2.0M $22.8M $21.2M
Net Cash from Operating Activities $-195.1K $-415.5K $-1.1M $-813.0K $-568.9K $-431.0K $-1.1M $-3.2M
Investing Activities
Capital Expenditures — — $10.0K $0 $271.2K $0 $3.0K $826.5K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — $1.6M $1.3M $-271.2K $163.6K $-3.0K $-876.5K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $70.1K $285.3K $-588.0K $-148.7K $848.6K $277.0K $1.0M $4.0M
Net Change in Cash — $-130.3K $-31.0K $295.4K $8.5K $9.6K $-67.5K $-90.6K
Free Cash Flow — — $-1.1M $-813.0K $-840.1K $-431.0K $-1.1M $-4.0M
← Newer Page 1 of 2 Older →